Cameco Corporation (USA)  

(Public, NYSE:CCJ)   Watch this stock  
Find more results for CCJ
19.16
-0.60 (-3.04%)
Sep 19 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 19.00 - 19.81
52 week 17.27 - 25.84
Open 19.79
Vol / Avg. 2.40M/1.53M
Mkt cap 7.83B
P/E 20.37
Div/yield 0.09/1.92
EPS 0.94
Shares 395.79M
Beta 1.58
Inst. own 70%
Oct 28, 2014
Q3 2014 Cameco Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 4, 2014
Cameco Corp at Bank of America Merrill Lynch Canada Mining Conference
Jul 31, 2014
Q2 2014 Cameco Corp Earnings Call
Jul 31, 2014
Q2 2014 Cameco Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin 25.27% 13.03%
Operating margin 16.53% 10.85%
EBITD margin - 25.60%
Return on average assets 6.06% 4.11%
Return on average equity 9.19% 6.19%
Employees 3,470 -
CDP Score - 64 D

Address

2121-11th Street West
SASKATOON, SK S7M 1J3
Canada
+1-306-9566200 (Phone)
+1-306-9566201 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Transcripts - SeekingAlpha

Description

Cameco Corporation (Cameco) is engaged in the exploration for and the development, mining, refining, conversion and fabrication of uranium for sale as fuel for generating electricity in nuclear power reactors in Canada and other countries. Cameco has a 31.6% interest in Bruce Power L.P. (BPLP), which operates the four Bruce B nuclear reactors in Ontario. Cameco has three reportable segments: uranium, fuel services and electricity. In January 2013, the Company acquired NUKEM Energy GmbH.

Officers and directors

Timothy S. Gitzel President, Chief Executive Officer, Director
Age: 51
Bio & Compensation  - Reuters
Grant E. Isaac Chief Financial Officer, Senior Vice President
Bio & Compensation  - Reuters
Robert A. Steane Chief Operating Officer, Senior Vice President
Bio & Compensation  - Reuters
Kenneth A. Seitz Senior Vice President, Chief Compliance Officer
Bio & Compensation  - Reuters
Sean Quinn Senior Vice President, Chief Legal Officer, Corporate Secretary
Bio & Compensation  - Reuters
Alice Wong Senior Vice President, Chief Corporate Officer
Bio & Compensation  - Reuters
Donald H. F. Deranger Director
Age: 58
Bio & Compensation  - Reuters
Catherine A. Gignac Director
Age: 52
Bio & Compensation  - Reuters
Victor J. Zaleschuk Director
Age: 70
Bio & Compensation  - Reuters
Ian D. Bruce Independent Director
Age: 60
Bio & Compensation  - Reuters